11 Recruiting Hepatic Impairment Phase 1 Clinical Trials

Active phase 1 studies for hepatic impairment enrolling across the USA. Verify eligibility and contact site coordinators.

All Hepatic Impairment studies

Phase 1 Studies for Hepatic Impairment

🟡 Not Yet Recruiting Phase1

A Phase I Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics, Safety, and Tolerability of AZD4144

📍 Research Site — Mesa, Arizona

View Study & Checklist ➔

🟢 Recruiting Phase1

A Study to Evaluate the Pharmacokinetics (PK) and Safety of a Single Dose of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Normal Hepatic Function and Participants With Hepatic Impairment

📍 Orlando County Research Center — Lake Forest, California

View Study & Checklist ➔

🟢 Recruiting Phase1

A Study to Learn How the Study Medicine Called Atirmociclib is Handled by the Body in People With Normal Liver Function and Different Levels of Liver Disease

📍 Floridian Clinical Research — Miami Lakes, Florida

View Study & Checklist ➔

🟢 Recruiting Phase1

A Phase I Study to Investigate the Effect of Hepatic Impairment of AZD9550 and AZD6234

📍 Research Site — Chandler, Arizona

View Study & Checklist ➔

🟢 Recruiting Phase1

Pharmacokinetics (PK) and Safety of Zanzalintinib in Participants With Moderate Hepatic Impairment (HI)

📍 Exelixis Clinical Site #1 — Orlando, Florida

View Study & Checklist ➔

🟢 Recruiting Phase1

Hepatic Impairment With Cirrhosis Due to Cholestatic Liver Disease

📍 Zydus US002 — Indianapolis, Indiana

View Study & Checklist ➔

🟢 Recruiting Phase1

Assessment of Quizartinib Pharmacokinetic in Subjects With Severe Hepatic Impairment

📍 Clinical Pharmacology of Miami, LLC — Miami, Florida

View Study & Checklist ➔

🟢 Recruiting Phase1

A Study to Learn How the Body Processes the Study Medicine PF-07328948 in People With and Without Reduced Liver Function

📍 Orange County Research Center — Lake Forest, California

View Study & Checklist ➔

🟢 Recruiting Phase1

A Study to Evaluate the Effect of Moderate or Severe Hepatic Impairment on the Pharmacokinetics (PK) of Inavolisib

📍 Orange County Research Center — Lake Forest, California

View Study & Checklist ➔

🟢 Recruiting Phase1

Effect of Hepatic Impairment on the Pharmacokinetics and Safety of VIR-2218 and VIR-3434

📍 Inland Empire Clinical Trials — Rialto, California

View Study & Checklist ➔

🟢 Recruiting Phase1

Radiprodil in Participants With Hepatic Impairment

📍 Epic Medical Research — DeSoto, Texas

View Study & Checklist ➔